Samik Pharmaceutical Company LTD. (KOSDAQ:014950)
South Korea · Delayed Price · Currency is KRW
16,210
-450 (-2.70%)
At close: Jan 29, 2026
KOSDAQ:014950 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| TTM | FY 2024 | FY 2023 |
|---|
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
|---|
| 3,267 | 3,522 | 2,969 |
Depreciation & Amortization | 1,386 | 1,351 | 1,278 |
Loss (Gain) From Sale of Assets | -2.77 | -9.5 | -0.07 |
Asset Writedown & Restructuring Costs | - | 23.8 | - |
Loss (Gain) From Sale of Investments | -308.4 | -300.14 | -298.32 |
| 266.53 | 263.58 | 72.69 |
Provision & Write-off of Bad Debts | -5.18 | -2.68 | -65.12 |
Other Operating Activities | 1,491 | 1,391 | 696.68 |
Change in Accounts Receivable | 3,380 | 558.63 | -1,117 |
| -3,612 | -2,105 | -55.64 |
Change in Accounts Payable | -2,256 | 251.69 | -827.43 |
| -136.55 | - | -3.98 |
Change in Other Net Operating Assets | -464.27 | -559.9 | -400.44 |
| 3,006 | 4,385 | 2,248 |
Operating Cash Flow Growth | 33.70% | 95.04% | - |
| -951.05 | -842.32 | -1,374 |
Sale (Purchase) of Intangibles | -8.1 | -5.83 | -3.14 |
| 805.62 | -1,613 | -120.5 |
Other Investing Activities | - | - | -70 |
| 146.47 | -2,161 | -1,868 |
| - | -137.56 | -109.02 |
| -109.38 | -137.56 | -109.02 |
| 672.3 | 672.3 | - |
| -250.09 | -281 | -140.5 |
Other Financing Activities | -1.47 | -1.02 | - |
| 311.36 | 252.72 | -249.52 |
Miscellaneous Cash Flow Adjustments | - | - | -0 |
| 3,464 | 2,477 | 130.88 |
| 2,055 | 3,543 | 874.05 |
| 135.11% | 305.32% | - |
| 3.49% | 6.34% | 1.71% |
| 288.12 | 503.91 | 124.52 |
| 2.1 | 12.04 | 18.36 |
| 458.25 | 205.69 | 3.03 |
| - | 3,382 | - |
| - | 3,389 | - |
Change in Working Capital | -3,089 | -1,854 | -2,405 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.